SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-04
👔
Krystal Biotech, Inc.
@KRYS_InsiderForm 4 Filing: Krishnan Suma Sells $9.0M of $KRYS
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
Krystal Biotech, Inc.
Ticker: $KRYS
Transaction Value
$9.0M
Price/Share: $359.32
transaction date
2026-09-04
Shares: 25,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Krishnan Suma, holds the title of President, R&D at Krystal Biotech, Inc..
On 2026-09-04, the insider transacted 25,000 shares.The shares were transacted at a weighted average price of $359.32 per share, resulting in a total market-relevant value of $9.0M.
Executive Summary Summary
Krishnan Suma (President, R&D) sold $9.0M of $KRYS
Post-Transaction Position: 1,317,390 shares
SEC Accession No: 0001298711-26-000009 (CIK: 1298711)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.